Acambis warns of delay in US contract
Tuesday 26 November 2002
Acambis, the biotech group whose fortunes were transformed by orders for a smallpox vaccine, admitted yesterday that it has suffered delays to its flagship contract to supply the US government.
The disappointment overshadowed news that the company has signed two more contracts with countries concerned about the threat of a bioterrorist attack.
Some £25m of revenue that had been expected to come through before Christmas will now be delayed into next year, after Acambis found itself unable to carry out the necessary testing on batches of the smallpox vaccine, which is made from cowpox.
John Brown, the chief executive, said: "We had a shortage of a chemical agent used in the testing, so we had the product backed up waiting to be tested. The revenue of $428m [£273m] from the contract is staying the same, the margins are staying the same, but some of the money that we said would come in during the fourth quarter of this year will now come in during the first quarter of next year."
The news sent Acambis shares down more than 10 per cent in early trading, but they recovered to close off only 4 per cent at 250.5p as analysts maintained their bullish stance. Nomura had been forecasting a maiden profit of £8.1m for 2002, and while that has now been reduced to £1.6m, the 2003 profit figure has grown from £27.7m to £36.1m.
Mr Brown refused to identify the two countries who have signed contracts for the supply of smallpox vaccine, but said they would be "small in comparison" with the US deal. Analysts expect revenues will be in "single-figure millions" of dollars.
A third country, Austria, has signalled its intention to buy smallpox vaccine from Acambis, but it is yet to sign a deal.
The US had a small supply deal with Acambis which it expanded after 11 September last year as fears grew that terrorists could use smallpox as a biological weapon. It is now buying 209 million doses, enough to inoculate every citizen.
- 1 What happens to your body when you give up sugar?
- 2 Licence fee: What is the BBC charge – and how will the changes affect you?
- 3 This is what the photographer has to say about the picture of a weasel riding a woodpecker
- 4 Delhi bus rapist blames dead victim for attack because 'girls are responsible for rape'
- 5 Have sex with your iPad thanks to the new sex toy no-one asked for
'Jihadi John': CAGE representative storms off Sky News accusing Kay Burley of Islamophobia
Durham Free School: 'Creationism taught at' free school facing closure
Ukip would cut billions from Scottish budget to fund English tax cuts
Nearly 100,000 of Britain's poorest children go hungry after parents' benefits are cut
End of the licence fee: BBC to back radical overhaul of how it is funded
Ukraine crisis: Top Chinese diplomat backs Putin and says West should 'abandon zero-sum mentality'
iJobs Money & Business
£15000 - £18000 per annum: Recruitment Genius: This is a great opportunity for...
£50000 - £60000 per annum + Excellent Salary: Austen Lloyd: An outstanding new...
£20000 - £21000 per annum + uncapped commission: SThree: As a graduate you are...
£25000 - £30000 per annum + benefits: Ashdown Group: A global leader operating...